MedTrace Logo

Clinical Pharmacology of Platinum-based Hyperthermic Intraperitoneal Chemotherapy

NCT03364907 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2020-10-20

No results posted yet for this study

Summary

Currently, there is a lack of knowledge on the effect of additional flushing after HIPEC on tumour platinum exposure, systemic platinum exposure and platinum concentration in drain exudate and thereby personal exposure. Therefore the investigators want to perform a study to investigate the effect of flushing after HIPEC on tumour exposure, systemic exposure and on wound exudate concentration.

Conditions

  • Peritoneal Carcinomatosis

Interventions

OTHER

HIPEC with flushing afterwards

flushing with saline fluid after HIPEC

OTHER

HIPEC without flushing afterwards

NO flushing with saline fluid after HIPEC

Sponsors & Collaborators

  • Radboud University Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2019-06-08
Completion
2019-12-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03364907 on ClinicalTrials.gov